Amgen to invest $200m to become carbon-neutral by 2027

The biopharmaceutical company has also set targets to reduce water consumption by 40% and waste disposed by 75%

US biopharmaceutical company Amgen has pledged to invest more than $200 million (£146m) as part of its ambition to become carbon-neutral by 2027.

Its goals has been unveiled in its new seven-year environmental sustainability plan, which also includes targets to reduce water consumption by 40% and waste disposed by 75%,

Since 2007, the company has implemented projects that have resulted in a 33% reduction in carbon emissions, a 30% fall in water use and a 28% reduction in waste.

Amgen says these reductions were achieved even as the company increased production capacity, expanded its presence to more than 100 countries and grew revenues “significantly”.

It intends to focus on the use of innovative technologies to significantly reduce carbon emissions from Amgen-owned operations, as well as on sourcing renewable energy.

When emissions cannot be eliminated, Amgen will invest in sustainability projects that sequester or avoid greenhouse gas emissions.

Chairman and CEO Robert A. Bradway said: “As a science-based company with a mission to serve patients, we understand the profound impact that climate change is having on human health around the world.

“Our new commitments expand on our previous achievements and drive’s continued leadership on environmental sustainability that will benefit our patients, staff, shareholders and communities.”

 

Latest Podcast